These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23850534)

  • 1. First report on exploring structural requirements of α and β thymidine analogs for PfTMPK inhibitory activity using in silico studies.
    Ojha PK; Roy K
    Biosystems; 2013 Sep; 113(3):177-95. PubMed ID: 23850534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Nov; 16(9):739-57. PubMed ID: 23701009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbocyclic thymidine derivatives efficiently inhibit Plasmodium falciparum thymidylate kinase (PfTMK).
    Kato A; Yasuda Y; Kitamura Y; Kandeel M; Kitade Y
    Parasitol Int; 2012 Sep; 61(3):501-3. PubMed ID: 22425904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
    Ojha PK; Roy K
    Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum.
    Cui H; Ruiz-Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2010 Oct; 18(20):7302-9. PubMed ID: 20833052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase.
    Noguchi Y; Yasuda Y; Tashiro M; Kataoka T; Kitamura Y; Kandeel M; Kitade Y
    Parasitol Int; 2013 Aug; 62(4):368-71. PubMed ID: 23583697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of α-thymidine analogues as novel antimalarials.
    Cui H; Carrero-Lérida J; Silva AP; Whittingham JL; Brannigan JA; Ruiz-Pérez LM; Read KD; Wilson KS; González-Pacanowska D; Gilbert IH
    J Med Chem; 2012 Dec; 55(24):10948-57. PubMed ID: 23240776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
    Gopalakrishnan B; Aparna V; Jeevan J; Ravi M; Desiraju GR
    J Chem Inf Model; 2005; 45(4):1101-8. PubMed ID: 16045305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore optimization and design of competitive inhibitors of thymidine monophosphate kinase through molecular modeling studies.
    Chitre TS; Kathiravan MK; Bothara KG; Bhandari SV; Jalnapurkar RR
    Chem Biol Drug Des; 2011 Nov; 78(5):826-34. PubMed ID: 21801308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
    Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D
    Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
    Aparna V; Jeevan J; Ravi M; Desiraju GR; Gopalakrishnan B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1014-20. PubMed ID: 16290929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the
    Enninful KS; Kwofie SK; Tetteh-Tsifoanya M; Lamptey ANL; Djameh G; Nyarko S; Ghansah A; Wilson MD
    Front Cell Infect Microbiol; 2022; 12():868529. PubMed ID: 35694550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
    Wadood A; Ulhaq ZU
    J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Comput Aided Mol Des; 2010 Feb; 24(2):157-72. PubMed ID: 20217185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of α-Thymidine Inhibitors with Thymidylate Kinase from Plasmodium falciparum.
    Chen MD; Sinha K; Rule GS; Ly DH
    Biochemistry; 2018 May; 57(19):2868-2875. PubMed ID: 29684273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies.
    Kandeel M; Kitade Y; Al-Taher A; Al-Nazawi M
    PLoS One; 2019; 14(2):e0212065. PubMed ID: 30730992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.